San Francisco, CA, United States of America

Geoffrey Horner

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ngm Biopharmaceuticals, Inc.. Active years: 2017-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Geoffrey Horner. Retrieved from https://idiyas.com/inventor/geoffrey-horner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Geoffrey Horner in Metabolic Disorder Treatments

Introduction

Geoffrey Horner is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of biopharmaceuticals, particularly in the treatment of metabolic disorders. With a total of 2 patents, his work focuses on innovative methods and compositions that address critical health issues.

Latest Patents

Horner's latest patents include groundbreaking compositions and methods for treating metabolic disorders. These patents specifically detail methods for treating individuals with glucose metabolism disorders and body weight disorders. The compositions associated with these methods are designed to provide effective treatment options for patients suffering from these conditions.

Career Highlights

Geoffrey Horner is currently employed at NGM Biopharmaceuticals, Inc., where he continues to develop and refine his innovative approaches to metabolic disorder treatments. His expertise and dedication to research have positioned him as a key figure in the biopharmaceutical industry.

Collaborations

Horner collaborates with talented professionals in his field, including Hugo Matern and Darrin Anthony Lindhout. These partnerships enhance the research and development efforts at NGM Biopharmaceuticals, Inc., fostering an environment of innovation and discovery.

Conclusion

Geoffrey Horner's contributions to the treatment of metabolic disorders through his patents and work at NGM Biopharmaceuticals, Inc. highlight his commitment to improving patient outcomes. His innovative approaches continue to pave the way for advancements in biopharmaceutical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…